Clinical Trials
660
Active:8
Completed:195
Trial Phases
6 Phases
Early Phase 1:9
Phase 1:93
Phase 2:63
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (453 trials with phase data)• Click on a phase to view related trials
Not Applicable
234 (51.7%)Phase 1
93 (20.5%)Phase 2
63 (13.9%)Phase 4
31 (6.8%)Phase 3
23 (5.1%)Early Phase 1
9 (2.0%)Colostrum from MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.
Phase 1
Completed
- Conditions
- COVID 19
- Interventions
- Biological: Colostrum Nasal SprayOther: Water for injection
- First Posted Date
- 2025-03-04
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 43
- Registration Number
- NCT06857318
- Locations
- 🇮🇱
Hadassah Hebrew University, Jerusalem, Israel
Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
Phase 4
Recruiting
- Conditions
- HIV Infected IndividualsOsteopenia
- Interventions
- Drug: Zoledronic Acid 5 mg/Bag 100 ml Inj
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 110
- Registration Number
- NCT06762730
- Locations
- 🇮🇱
Rambam Medical Center, Hiafa, Israel
🇮🇱Hadassah Hebrew University Medical Center, Jerusalem, Israel
🇮🇱Sheba Medical Center, Tel Hashmer, Israel
The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma
Active, not recruiting
- Conditions
- Cholangiocarcinoma
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 50
- Registration Number
- NCT06707025
- Locations
- 🇮🇱
Hdassah Hospital, Jerusalem, Israel
Identifying Tissue-of-origin in Transplant Patients and Patients with Malignancies.
Active, not recruiting
- Conditions
- Malignancies
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 1000
- Registration Number
- NCT06703853
- Locations
- 🇮🇱
Hdassah Hospital, Jerusalem, Israel
Postural Management of Hyperkyphosis in Cardiac Rehab Patients
Not Applicable
Recruiting
- Conditions
- Hyperkyphosis
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 60
- Registration Number
- NCT06563882
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israek, Israel
- Prev
- 1
- 2
- 3
- 4
- 5
- 132
- Next
News
No news found